Derek Rapp
Chairman Of The Board (Non-Executive) @ WeedOut
St Louis, United States
Derek Rapp is a Series A investor at WeedOut in St Louis focused on Health Care and Biotechnology. Derek K. Rapp is the Managing Director at RiverVest Venture Partners. Derek K. Rapp attended University of Pennsylvania - The Wharton School.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Derek Rapp invests in
Stages Derek Rapp invests in
Countries Derek Rapp invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AnTolRx
|
At AnTolRx they are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include life threatening infections and tumors. Thus, there is an unmetclinical need for methods of targeted immune-regulation. Their proprietary drug development approach selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases. | $4M / Series A / Sep 08, 2016 |
Co-Investors
About WeedOut
WeedOut is a biotechnology company focusing on providing weed control solutions. The company’s goal is to reduce the need for toxic herbicides and higher herbicide doses.
WeedOut Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Derek K. Rapp
Chairman Of The Board (Non-Executive)
|
|||
|
Derek Rapp
Chairman Of The Board (Non-Executive)
|
|||
Efrat Lidor Nili
Co-Founder & Co-CEO
|
|||
Orly Noivirt-Brik
Co-Founder & Co-CEO
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Derek Rapp invest in?
Derek Rapp invests primarily in Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Derek Rapp last invest?
The most recent investment recorded for Derek Rapp closed in Sep 2016. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
